171 related articles for article (PubMed ID: 30031680)
1. Cytokines and CD8 T cell immunity during respiratory syncytial virus infection.
Schmidt ME; Varga SM
Cytokine; 2020 Sep; 133():154481. PubMed ID: 30031680
[TBL] [Abstract][Full Text] [Related]
2. Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology.
Shilovskiy IP; Yumashev KV; Nikolsky AA; Vishnyakova LI; Khaitov MR
Biochemistry (Mosc); 2021 Mar; 86(3):290-306. PubMed ID: 33838630
[TBL] [Abstract][Full Text] [Related]
3. The Human Immune Response to Respiratory Syncytial Virus Infection.
Russell CD; Unger SA; Walton M; Schwarze J
Clin Microbiol Rev; 2017 Apr; 30(2):481-502. PubMed ID: 28179378
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.
González PA; Prado CE; Leiva ED; Carreño LJ; Bueno SM; Riedel CA; Kalergis AM
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14999-5004. PubMed ID: 18818306
[TBL] [Abstract][Full Text] [Related]
5. A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.
Lukens MV; van de Pol AC; Coenjaerts FE; Jansen NJ; Kamp VM; Kimpen JL; Rossen JW; Ulfman LH; Tacke CE; Viveen MC; Koenderman L; Wolfs TF; van Bleek GM
J Virol; 2010 Mar; 84(5):2374-83. PubMed ID: 20015982
[TBL] [Abstract][Full Text] [Related]
6. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.
Salaun B; De Smedt J; Vernhes C; Moureau A; Öner D; Bastian AR; Janssens M; Balla-Jhagjhoorsingh S; Aerssens J; Lambert C; Coenen S; Butler CC; Drysdale SB; Wildenbeest JG; Pollard AJ; Openshaw PJM; Bont L
Front Immunol; 2023; 14():1260146. PubMed ID: 37936699
[TBL] [Abstract][Full Text] [Related]
7. Interactions between RSV infection, asthma, and atopy: unraveling the complexities.
Holt PG; Sly PD
J Exp Med; 2002 Nov; 196(10):1271-5. PubMed ID: 12438419
[No Abstract] [Full Text] [Related]
8. Monocyte production of C1q potentiates CD8
Eddens T; Parks OB; Lou D; Fan L; Sojati J; Ramsey MJ; Schmitt L; Salgado CM; Reyes-Mugica M; Oury TD; Byersdorfer C; Chen K; Williams JV
bioRxiv; 2023 Jun; ():. PubMed ID: 37333212
[TBL] [Abstract][Full Text] [Related]
9. The immune battlefield: The impact of inflammatory cytokines on CD8+ T-cell immunity.
Condotta SA; Richer MJ
PLoS Pathog; 2017 Oct; 13(10):e1006618. PubMed ID: 29073270
[No Abstract] [Full Text] [Related]
10. Monocyte Production of C1q Potentiates CD8
Eddens T; Parks OB; Lou D; Fan L; Sojati J; Ramsey MJ; Schmitt L; Salgado CM; Reyes-Mugica M; Evans A; Zou HM; Oury TD; Byersdorfer C; Chen K; Williams JV
Am J Respir Cell Mol Biol; 2024 May; ():. PubMed ID: 38696270
[TBL] [Abstract][Full Text] [Related]
11. IL-1α is required for T cell-driven weight loss after respiratory viral infection.
Wang Z; Cuthbertson LF; Thomas C; Sallah HJ; Mosscrop LG; Li H; Talts T; Kumar K; Moffatt MF; Tregoning JS
Mucosal Immunol; 2024 Apr; 17(2):272-287. PubMed ID: 38382577
[TBL] [Abstract][Full Text] [Related]
12.
Zelaya H; Arellano-Arriagada L; Fukuyama K; Matsumoto K; Marranzino G; Namai F; Salva S; Alvarez S; Agüero G; Kitazawa H; Villena J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069229
[No Abstract] [Full Text] [Related]
13. Genome-wide study of globally distributed respiratory syncytial virus (RSV) strains implicates diversification utilizing phylodynamics and mutational analysis.
Shishir TA; Saha O; Rajia S; Mondol SM; Masum MHU; Rahaman MM; Hossen F; Bahadur NM; Ahmed F; Naser IB; Amin MR
Sci Rep; 2023 Aug; 13(1):13531. PubMed ID: 37598270
[TBL] [Abstract][Full Text] [Related]
14. IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.
Pulkina A; Vasilyev K; Muzhikyan A; Sergeeva M; Romanovskaya-Romanko E; Shurygina AP; Shuklina M; Vasin A; Stukova M; Egorov A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511205
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Therapy of COVID-19.
Gudima G; Kofiadi I; Shilovskiy I; Kudlay D; Khaitov M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240213
[TBL] [Abstract][Full Text] [Related]
16. The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein.
Jenkins VA; Hoet B; Hochrein H; De Moerlooze L
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851260
[TBL] [Abstract][Full Text] [Related]
17. Remodeling and Restraining Lung Tissue Damage Through the Regulation of Respiratory Immune Responses.
Pyung YJ; Park DJ; Kim CG; Yun CH
Tissue Eng Regen Med; 2023 Jun; 20(3):329-339. PubMed ID: 36763280
[TBL] [Abstract][Full Text] [Related]
18. Preservation of antigen-specific responses in cryopreserved CD4
Clarkson BD; Johnson RK; Bingel C; Lothaller C; Howe CL
J Transl Autoimmun; 2022; 5():100173. PubMed ID: 36467614
[TBL] [Abstract][Full Text] [Related]
19. Alveolar macrophages and airway hyperresponsiveness associated with respiratory syncytial virus infection.
Wang Y; Zheng J; Wang X; Yang P; Zhao D
Front Immunol; 2022; 13():1012048. PubMed ID: 36341376
[TBL] [Abstract][Full Text] [Related]
20. The modulatory action of C-Vx substance on the immune system in COVID-19.
Tahrali I; Akdeniz N; Yilmaz V; Kucuksezer UC; Oktelik FB; Ozdemir O; Cetin-Aktas E; Ogutmen Y; Ergen A; Abaci N; Tuzun E; Oncul O; Deniz G
Emerg Microbes Infect; 2022 Dec; 11(1):2698-2710. PubMed ID: 36106521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
